Why Publish with Clinical Infectious Diseases?
Clinical Infectious Diseases (CID) is a leading journal in the field of infectious diseases with a broad international readership and is an official journal of the Infectious Diseases Society of America.
CID publishes original research, reviews, guidelines and perspectives that all clinicians can use when caring for patients. CID covers the clinical presentation, diagnosis, treatment and prevention of the full range of infectious diseases. The evaluation of current and novel treatments, microbiology, immunology and policies as they related to patient care are highly prioritized. With an Impact Factor of 8.2, the journal is ranked 9 out of 132 journals in the field of infectious diseases.
Fast publication speed
Manuscripts are first published within 24-72 hours of acceptance; corrected proofs are published within 3-5 weeks.
Ease of submission
The journal offers format-free submissions, as well as an efficient transfer process to The Journal of Infectious Diseases or Open Forum Infectious Diseases.
Distinguished Editorial Board
Members of the CID Editorial Board are recruited and appointed based on their expertise in the field. The board ensures the journal publishes high-quality content, operates ethically, and provides a welcoming publishing outlet for authors from all backgrounds and at all career stages.
Meet CID’s Editor in Chief
Paul E. Sax, MD, is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital and Professor of Medicine at Harvard Medical School. An internationally recognized clinician and clinical teacher in infectious diseases (in particular HIV), Dr. Sax is also involved in clinical research, including trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and assessments of toxicity of antiretroviral therapy. Find Dr. Sax on X @PaulSaxMD. Discoverability
Authors publishing in the journal benefit from a wide array of services to help support discoverability, including OUP’s platform capabilities, self-promotion tools, and IDSA’s social media and other communications vehicles, including CID’s X presence. With an average of more than 750,000 visits with content engagement per month, your article will receive significant exposure.
Open Access
If you prefer to make your work available under an open access license, or your funder requires open access publication, CID offers various options. For more details, see Clinical Infectious Disease's charges.
Ready to submit?
